ArticleHeart and vessels2013

Effects of aliskiren on the fibrinolytic system in patients with coronary artery disease receiving angiotensin-converting enzyme inhibitor or angiotensin II type 1 receptor blocker.

Ken Ishibashi et al.PubMed ↗Publisher ↗

No numbers read from the abstract.